Psychological Intervention Mobile App for Patients With AML
NCT03372291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-08-13
Summary
This research study is evaluating the impact of a psychological intervention mobile application (app) on the quality of life, mood, and symptoms of patients with acute myeloid leukemia (AML).
Conditions
Interventions
- OTHER
-
Usual Care
Usual leukemia care with all the supportive care measures instituted by the leukemia team
- OTHER
-
Psychological intervention
Psychological intervention is focused on educating patients about leukemia and how to cope with its treatment
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Areej El-Jawahri, MD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2021-07-01
- Completion
- 2024-07-01
Countries
- United States
Study Locations
More Related Trials
-
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
NCT03597321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
NCT06697600 ·Status: RECRUITING ·Phase: NA
-
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
NCT04293562 ·Status: RECRUITING ·Phase: PHASE3
-
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT04745676 ·Status: COMPLETED ·Phase: NA
-
Assessing Refractoriness and Infectious Survival Events in AML
NCT06709235 ·Status: COMPLETED
-
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
NCT02662920 ·Status: COMPLETED
-
Novel Digital Application for Patients With Acute Leukemia
NCT06472128 ·Status: RECRUITING ·Phase: NA
-
Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)
NCT00880243 ·Status: COMPLETED ·Phase: PHASE3
-
Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival
NCT01188330 ·Status: UNKNOWN ·Phase: NA
-
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
NCT05237258 ·Status: RECRUITING ·Phase: NA
-
Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients
NCT02863302 ·Status: UNKNOWN ·Phase: NA
-
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases
NCT03959007 ·Status: COMPLETED ·Phase: NA
-
Lenalidomide Plus Chemotherapy for AML
NCT01681537 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
NCT00049517 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
NCT00504920 ·Status: COMPLETED
-
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT00459524 ·Status: COMPLETED
-
Transfusion in Adult Acute Myeloid Leukemia
NCT02899767 ·Status: COMPLETED
-
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
NCT00525746 ·Status: UNKNOWN
-
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NCT06879847 ·Status: RECRUITING ·Phase: NA
-
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
NCT00909168 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)
NCT02662933 ·Status: COMPLETED ·Phase: NA
-
Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
NCT06050941 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814 ·Status: RECRUITING ·Phase: PHASE3
-
Microtransplantation in Older Patients With Acute Myeloid Leukemia
NCT02831192 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
NCT01339910 ·Status: TERMINATED ·Phase: PHASE3